AXA Research Fund has a mission to support research aimed at solving very concrete issues, particularly in the domain of health.
In 2009, AXA made a capital endowment donation of €2.25m to establish a chair in supramolecular chemistry in Strasbourg.
As a capital endowment, it meant that Luisa De Cola, the renowned researcher specially recruited for the creation of the chair, had permanent resources at her disposal to conduct her research.
The researcher developed nano-containers capable of transporting drugs, DNA or enzymes to the target diseased cells, an alternative to classic chemotherapy that also raised the hope of new treatments for age-related illnesses.
Luisa De Cola has brilliantly demonstrated her effectiveness at producing results in research applied to medicine: since 2013, her laboratory has published 90 articles, filed 32 patents and created a start-up!